Isovalerylglycine as biomarker for the predispositon for weight gain and obesity
US9500660B2 · kind B2 · utility
1Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2013 |
| Grant date | Nov 22, 2016 |
| Priority date | — |
| Expiry date | Nov 25, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/70
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to a new biomarker, its use and a method that allows it to diagnose the likelihood to resist diet induced weight gain, and/or to be susceptible to a diet induced weight gain. For example, the biomarker may be isovalerylglycine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.